Displaying 1 - 20 of 27
FTC Staff Comment to the FDA Department of Health and Human Services on Its Updated Guidance for Industry on the “Nonproprietary Naming of Biological Productsâ€
Date
Matter Number
V190001
Docket Number
FDA-2013-D-1543
File
Text of the FTC Staff Comment
(52.95 KB)
Comment of Jessica L. Rich, Director, Bureau of Consumer Protection, to the National Highway Traffic Safety Administration Supporting the Inclusion of Consumer Privacy and Cybersecurity Guidance in the Document “Â鶹´«Ã½ Automated Vehicles Policyâ€
Date
Matter Number
P135405
Docket Number
NHTSA-2016-0090
BCP Director Jessica L. Rich submitted a comment to NHTSA regarding its request for comments on proposed industry guidance for highly automated vehicles. Rich commends NHTSA for its “thoughtful...
FTC Staff Comment to the Â鶹´«Ã½ Communications Commission: Rules and Regulations Implementing the Telephone Consumer Protection Act of 1991: Proposed FCC Rule Amendments To Limit Robocalls To Consumers
Date
Matter Number
P064803
Docket Number
CG Docket No. 02-278
FTC staff submitted a comment to the FCC regarding proposed amendments to the FCC regulations that limit robocalls to consumers. The proposed amendments implement a recent change in the law that...
File
Text of the FTC Staff Comment
(105.29 KB)
Joint Comment of the Â鶹´«Ã½ Trade Commission Staff and the Antitrust Division to North Carolina State Senator Bill Cook on North Carolina HB 436 Concerning Online Legal Forms and the Practice of Law
Date
Matter Number
V160012
FTC staff and the U.S. Department of Justice Antitrust Division submitted a joint comment, in response to a request from North Carolina State Senator Bill Cook, on the impact of interactive websites...
File
FTC Staff Comment to the Â鶹´«Ã½ Communications Commission: In the Matter of Protecting the Privacy of Customers of Broadband and Other Telecommunications Services
Date
Matter Number
P165405
Docket Number
16-106
FTC staff submitted a comment to the FCC regarding its proposed privacy rulemaking for broadband internet access service providers. The comment responds to questions from the FCC and offers suggested...
File
Text of the FTC Staff Comment
(231.27 KB)
FTC Staff Comment Before the Food and Drug Administration Regarding the Current Use of Human Drug and Biological Products Labeled As Homeopathic, and the FDA's Regulatory Framework For Such Products
Date
Matter Number
P114505
Docket Number
80 Fed. Reg. 16327 (Mar. 27, 2015)
FTC staff has recommended that the U.S. Food and Drug Administration (FDA) reconsider the framework it uses to regulate homeopathic medications because it may appear to conflict with the FTC’s...
File
Exhibit A
(1.61 MB)
File
Exhibit B-Part 1
(2.51 MB)
File
Exhibit B-Part 2
(3.34 MB)
File
Exhibit C
(5.08 MB)
FTC Staff Comment to New York State Senator Ranzenhofer and New York State Assemblyman Abinanti Concerning SB 2647 and AB 2888 Authorizing Certain Agreements for the Creation and Operation of a Health Care Delivery System Network
Date
Matter Number
V150005
FTC staff submitted a comment to New York Senator Michael H. Ranzenhofer and New York Assemblyman Thomas Abinanti regarding the possible effects of a legislative proposal that would authorize Erie...
Displaying 1 - 20 of 27